PTHLH
Parathyroid hormone-related protein
Also known as: HHM, PLP, PTHR, PTHR_HUMAN, PTHRP
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P12272
- Gene
- PTHLH
- Ensembl
- ENSG00000087494
- Chromosome
- 12
- Canonical length
- 177 aa
- Protein class
- Cancer-related genes, Disease related genes, Human disease related genes, Predicted secreted proteins
- Subcellular location
- Nucleoplasm,Golgi apparatus,Cytosol
- Secretome location
- Secreted in other tissues
OverviewNCBI Gene
The protein encoded by this gene is a member of the parathyroid hormone family. This hormone, via its receptor, PTHR1, regulates endochondral bone development and epithelial-mesenchymal interactions during the formation of the mammary glands and teeth. It is responsible for most cases of humoral hypercalcemia of malignancy, and mutations in this gene are associated with brachydactyly type E2 (BDE2). Alternatively spliced transcript variants have been found for this gene. There is also evidence for alternative translation initiation from non-AUG (CUG and GUG) start sites, downstream of the initiator AUG codon, resulting in nuclear forms of this hormone. [provided by RefSeq, Nov 2013]
Canonical amino-acid sequenceUniProt
177 residues, UniProt reviewed canonical sequence.
>P12272|PTHLH
1 MQRRLVQQWS VAVFLLSYAV PSCGRSVEGL SRRLKRAVSE HQLLHDKGKS IQDLRRRFFL
61 HHLIAEIHTA EIRATSEVSP NSKPSPNTKN HPVRFGSDDE GRYLTQETNK VETYKEQPLK
121 TPGKKKKGKP GKRKEQEKKK RRTRSAWLDS GVTGSGLEGD HLSDTSTTSL ELDSRRHLocalizationUniProt · AlphaFold · HPA
Whether an antibody against PTHLH can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Secreted
- Secreted
- Yes
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.65
- Highest tissue expression
- 21 nTPM
Expression across tissuesHPA
Tissue
- parathyroid gland: 21 nTPM
- breast: 19 nTPM
- vagina: 16 nTPM
- esophagus: 15 nTPM
- choroid plexus: 14 nTPM
- cervix: 12 nTPM
Single-cell type
- breast lactating cells: 423 nCPM
- breast hormone-responsive cells: 155 nCPM
- esophageal basal cells: 33 nCPM
- salivary basal cells: 31 nCPM
- breast secretory cells: 22 nCPM
- breast myoepithelial cells: 20 nCPM
Immune cell
- T-reg: 0.6 nTPM
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
Brain region
- choroid plexus: 26 nTPM
- thalamus: 21 nTPM
- midbrain: 20 nTPM
- cerebral cortex: 12 nTPM
- medulla oblongata: 12 nTPM
- hypothalamus: 9.2 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about PTHLH.
Disease | AllUniProt
Conditions PTHLH is implicated in, by any mechanism.
- Brachydactyly E2 (BDE2) MIM:613382
Disease | GeneticClinVar
21 pathogenic / likely-pathogenic of 127 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Brachydactyly type E2
- Inborn genetic diseases
Disease | ImmuneIEDB
Conditions an epitope on PTHLH was assayed in.
- prostate cancer B and T cell
- castration-resistant prostate carcinoma B and T cell
- carcinoma B and T cell
- triple-receptor negative breast cancer B and T cell
- Her2-receptor negative breast cancer B and T cell
- Her2-receptor positive breast cancer B and T cell
- colorectal cancer B and T cell
- leiomyosarcoma B and T cell
- prostate carcinoma T cell
- prostatic urethral cancer B and T cell
- cancer B cell
- pancreatic carcinoma B cell
- lung small cell carcinoma B cell
- adult hepatocellular carcinoma B cell
- esophageal cancer B and T cell
- hematologic cancer B cell
- hepatocellular carcinoma B cell
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.48
- gnomAD pLI
- 0.81
- gnomAD missense Z
- 1.15
- DepMap mean gene effect
- 0.03
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- adenylate cyclase-activating G protein-coupled cAMP receptor signaling pathway
- adenylate cyclase-activating G protein-coupled receptor signaling pathway
- bone mineralization
- cAMP metabolic process
- cell-cell signaling
- epidermis development
- female pregnancy
- negative regulation of cell population proliferation
- negative regulation of chondrocyte development
- negative regulation of chondrocyte differentiation
- osteoblast development
- positive regulation of cell population proliferation
- regulation of chondrocyte differentiation
- regulation of gene expression
- skeletal system development
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Parathyroid hormone/parathyroid hormone-related protein
- Parathyroid hormone family
- Parathyroid hormone-related protein
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of PTHLH in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads PTHLH as an antibody target. Whether an autoantibody or antibody against PTHLH could matter depends on whether native PTHLH is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
PTHLH is annotated as secreted, so native PTHLH circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.
Source-annotated serology context
The source annotations explicitly mention antibody, autoantibody, autoantigen, or autoimmune context. This is biological context, not study-specific reactivity.
- It is responsible for most cases of humoral hypercalcemia of malignancy, and mutations in this gene are associated with brachydactyly type E2 (BDE2).
Loading the interactive Seroatlas protein explorer...